Evaluation of the potential use of hybrid LC-MS/MS for active drug quantification applying the 'free analyte QC concept'

13Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aim: Assessment of active drug exposure of biologics may be crucial for drug development. Typically, ligand-binding assay methods are used to provide free/active drug concentrations. To what extent hybrid LC-MS/MS procedures enable correct 'active' drug quantification is currently under consideration. Experimental & results: The relevance of appropriate extraction condition was evaluated by a hybrid target capture immuno-affinity LC-MS/MS method using total and free/active quality controls (QCs). The rapid extraction (10 min) provided correct results, whereas overnight incubation resulted in significant overestimation of the free/active drug (monclonal antibody) concentration. Conventional total QCs were inappropriate to determine optimal method conditions in contrast to free/active QCs. Conclusion: The 'free/active analyte QC concept' enables development of appropriate extraction conditions for correct active drug quantification by hybrid LC-MS/MS.

Author supplied keywords

References Powered by Scopus

Bioanalytical approaches to quantify "total" and "free" therapeutic antibodies and their targets: Technical challenges and PK/PD applications over the course of drug development

242Citations
N/AReaders
Get full text

Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies

238Citations
N/AReaders
Get full text

Recommendations for Validation of LC-MS/MS Bioanalytical Methods for Protein Biotherapeutics

152Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Protein quantification by LC-MS: A decade of progress through the pages of Bioanalysis

59Citations
N/AReaders
Get full text

Optimizing hybrid LC-MS/MS binding conditions is critical: Impact of biotransformation on quantification of trastuzumab

20Citations
N/AReaders
Get full text

2021 White Paper on Recent Issues in Bioanalysis: ISR for Biomarkers, Liquid Biopsies, Spectral Cytometry, Inhalation/Oral & Multispecific Biotherapeutics, Accuracy/LLOQ for Flow Cytometry (Part 2- Recommendations on Biomarkers/CDx Assays Development & Validation, Cytometry Validation & Innovation, Biotherapeutics PK LBA Regulated Bioanalysis, Critical Reagents & Positive Controls Generation)

19Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Jordan, G., Onami, I., Heinrich, J., & Staack, R. F. (2017). Evaluation of the potential use of hybrid LC-MS/MS for active drug quantification applying the “free analyte QC concept.” Bioanalysis, 9(21), 1705–1717. https://doi.org/10.4155/bio-2017-0158

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

67%

Researcher 1

33%

Readers' Discipline

Tooltip

Chemistry 2

50%

Agricultural and Biological Sciences 1

25%

Pharmacology, Toxicology and Pharmaceut... 1

25%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free